Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$24.68
0.903.78%
At close: Dec 10, 4:00 PM EST
$24.68
N/A
After Hours: 4:00 PM EST
Comments
Loading...
Apellis Pharmaceuticals (APLS) Stock Price, Quote, News & History
APLSNASDAQ
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS better than industry
FAQ
How do I buy Apellis Pharmaceuticals (APLS) stock?
You can purchase shares of Apellis Pharmaceuticals (NASDAQ:APLS) through any online brokerage.
Who are Apellis Pharmaceuticals (APLS) competitors?
Other companies in Apellis Pharmaceuticals’s space includes: IDEAYA Biosciences Inc (NASDAQ:IDYA), Ultragenyx Pharmaceutical Inc (NASDAQ:RARE), Sarepta Therapeutics Inc (NASDAQ:SRPT), Ascentage Pharma Group International (NASDAQ:AAPG) and Xenon Pharmaceuticals Inc (NASDAQ:XENE).
What is the forecast, or price target, for Apellis Pharmaceuticals (APLS) stock?
Apellis Pharmaceuticals has a consensus price target of $37.77.
What is the current price for Apellis Pharmaceuticals (APLS)?
The stock price for Apellis Pharmaceuticals (NASDAQ: APLS) is $24.68 last updated December 10, 2025 at 4:00 PM EST.
Does Apellis Pharmaceuticals (APLS) pay a dividend?
There are no upcoming dividends for Apellis Pharmaceuticals.
When is Apellis Pharmaceuticals (NASDAQ:APLS) reporting earnings?
Apellis Pharmaceuticals does not have any upcoming earnings scheduled.
Is Apellis Pharmaceuticals (APLS) going to split?
There is no upcoming split for Apellis Pharmaceuticals.
What sector and industry does Apellis Pharmaceuticals (APLS) operate in?
Apellis Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
